Csenge Advisory Group’s Pfizer PFE Stock Holding History

Csenge Advisory Group’s Portfolio PFE Stock Details PFE Fund Activity

Quarter	Market Value	Status	Shares	Shares Change %	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	$2.08M	Buy	88,444 +4,175	+5%	+$98.1K	0.11%	155
2025 Q1	$1.87M	Buy	84,269 +45,214	+116%	+$1M	0.11%	159
2024 Q4	$1.04M	Sell	39,055 -6,518	-14%	-$173K	0.06%	260
2024 Q3	$1.33M	Sell	45,573 -1,327	-3%	-$38.7K	0.07%	207
2024 Q2	$1.31M	Buy	46,900 +1,305	+3%	+$36.5K	0.07%	199
2024 Q1	$1.27M	Sell	45,595 -3,370	-7%	-$93.5K	0.07%	216
2023 Q4	$1.41M	Sell	48,965 -11,360	-19%	-$327K	0.09%	187
2023 Q3	$2M	Buy	60,325 +4,208	+7%	+$140K	0.14%	132
2023 Q2	$2.06M	Sell	56,117 -1,196	-2%	-$43.9K	0.14%	122
2023 Q1	$2.34M	Sell	57,313 -78	-0.1%	-$3.18K	0.17%	114
2022 Q4	$2.94M	Buy	57,391 +178	+0.3%	+$9.12K	0.23%	81
2022 Q3	$2.5M	Sell	57,213 -3,291	-5%	-$144K	0.21%	91
2022 Q2	$3.17M	Buy	60,504 +6,995	+13%	+$367K	0.27%	77
2022 Q1	$2.77M	Buy	53,509 +3,876	+8%	+$201K	0.22%	81
2021 Q4	$1.96M	Buy	49,633 +6,450	+15%	+$255K	0.17%	107
2021 Q3	$1.85M	Sell	43,183 -6,450	-13%	-$277K	0.16%	114
2021 Q2	$1.96M	Buy	49,633 +20,529	+71%	+$812K	0.17%	107
2021 Q1	$1.07M	Sell	29,104 -8,213	-22%	-$301K	0.11%	151
2020 Q4	$1.37M	Sell	37,317 -2,649	-7%	-$97.5K	0.16%	102
2020 Q3	$1.37M	Buy	39,966 +1,227	+3%	+$42.1K	0.19%	90
2020 Q2	$1.2M	Buy	38,739 +16,176	+72%	+$502K	0.17%	103
2020 Q1	$699K	Buy	22,563 +6,573	+41%	+$204K	0.18%	112
2019 Q4	$594K	Buy	15,990 +857	+6%	+$31.8K	0.15%	136
2019 Q3	$516K	Sell	15,133 -8,213	-35%	-$280K	0.14%	141
2019 Q2	$959K	Buy	23,346 +3,398	+17%	+$140K	0.33%	57
2019 Q1	$803K	Sell	19,948 -10,560	-35%	-$425K	0.28%	69
2018 Q4	$1.26M	Buy	30,508 +2,746	+10%	+$114K	0.46%	45
2018 Q3	$1.13M	Buy	27,762 +12,945	+87%	+$527K	0.44%	47
2018 Q2	$510K	Sell	14,817 -1,140	-7%	-$39.2K	0.19%	116
2018 Q1	$537K	Buy	15,957 +3,518	+28%	+$118K	0.19%	123
2017 Q4	$427K	Buy	+12,439	New	+$427K	0.15%	121